ELV logo

Elevance Health, Inc. (ELV) Free cash flow

annual FCF:

$4.55B-$2.21B(-32.71%)
December 31, 2024

Summary

  • As of today (August 26, 2025), ELV annual free cash flow is $4.55 billion, with the most recent change of -$2.21 billion (-32.71%) on December 31, 2024.
  • During the last 3 years, ELV annual FCF has fallen by -$2.73 billion (-37.45%).
  • ELV annual FCF is now -52.91% below its all-time high of $9.67 billion, reached on December 31, 2020.

Performance

ELV Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

quarterly FCF:

$1.79B+$966.00M(+117.66%)
June 30, 2025

Summary

  • As of today (August 26, 2025), ELV quarterly free cash flow is $1.79 billion, with the most recent change of +$966.00 million (+117.66%) on June 30, 2025.
  • Over the past year, ELV quarterly FCF has increased by +$1.66 billion (+1341.13%).
  • ELV quarterly FCF is now -71.03% below its all-time high of $6.17 billion, reached on March 31, 2023.

Performance

ELV quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

TTM FCF:

$5.34B+$1.66B(+45.26%)
June 30, 2025

Summary

  • As of today (August 26, 2025), ELV TTM free cash flow is $5.34 billion, with the most recent change of +$1.66 billion (+45.26%) on June 30, 2025.
  • Over the past year, ELV TTM FCF has increased by +$4.52 billion (+550.85%).
  • ELV TTM FCF is now -52.04% below its all-time high of $11.13 billion, reached on March 31, 2023.

Performance

ELV TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ELV Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-32.7%+1341.1%+550.9%
3 y3 years-37.5%-17.1%-33.5%
5 y5 years-8.7%-66.1%-46.4%

ELV Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.5%at low-71.0%+154.2%-52.0%+550.9%
5 y5-year-52.9%at low-71.0%+154.2%-52.0%+550.9%
alltimeall time-52.9%>+9999.0%-71.0%+154.2%-52.0%+3092.0%

ELV Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.79B(+117.7%)
$5.34B(+45.3%)
Mar 2025
-
$821.00M(+113.8%)
$3.67B(-19.3%)
Dec 2024
$4.55B(-32.7%)
$384.00M(-83.6%)
$4.55B(+422.6%)
Sep 2024
-
$2.35B(+1791.1%)
$871.00M(+6.2%)
Jun 2024
-
$124.00M(-92.7%)
$820.00M(-64.3%)
Mar 2024
-
$1.70B(-151.5%)
$2.30B(-66.1%)
Dec 2023
$6.76B(-6.7%)
-$3.30B(-243.7%)
$6.76B(-18.0%)
Sep 2023
-
$2.29B(+43.4%)
$8.25B(-22.0%)
Jun 2023
-
$1.60B(-74.1%)
$10.57B(-5.0%)
Mar 2023
-
$6.17B(-439.6%)
$11.13B(+53.6%)
Dec 2022
$7.25B(-0.4%)
-$1.82B(-139.3%)
$7.25B(-30.3%)
Sep 2022
-
$4.62B(+114.1%)
$10.39B(+29.6%)
Jun 2022
-
$2.16B(-5.7%)
$8.02B(+10.5%)
Mar 2022
-
$2.29B(+71.7%)
$7.26B(-0.2%)
Dec 2021
$7.28B(-24.7%)
$1.33B(-40.7%)
$7.28B(-23.2%)
Sep 2021
-
$2.25B(+60.7%)
$9.48B(+64.1%)
Jun 2021
-
$1.40B(-39.2%)
$5.78B(-40.2%)
Mar 2021
-
$2.30B(-34.9%)
$9.66B(-0.1%)
Dec 2020
$9.67B(+94.0%)
$3.54B(-342.8%)
$9.67B(+36.0%)
Sep 2020
-
-$1.46B(-127.6%)
$7.11B(-28.6%)
Jun 2020
-
$5.28B(+128.3%)
$9.96B(+68.8%)
Mar 2020
-
$2.31B(+136.8%)
$5.90B(+18.4%)
Dec 2019
$4.98B(+90.3%)
$976.00M(-30.1%)
$4.98B(+20.1%)
Sep 2019
-
$1.40B(+14.8%)
$4.15B(+38.1%)
Jun 2019
-
$1.22B(-12.9%)
$3.01B(+49.0%)
Mar 2019
-
$1.40B(+876.2%)
$2.02B(-22.9%)
Dec 2018
$2.62B(-22.6%)
$143.00M(-43.1%)
$2.62B(+193.8%)
Sep 2018
-
$251.40M(+10.3%)
$891.50M(-68.5%)
Jun 2018
-
$227.90M(-88.6%)
$2.83B(+0.2%)
Mar 2018
-
$2.00B(-226.0%)
$2.82B(-16.6%)
Dec 2017
$3.39B(+29.2%)
-$1.58B(-172.5%)
$3.39B(-33.3%)
Sep 2017
-
$2.19B(+878.1%)
$5.08B(+37.6%)
Jun 2017
-
$223.50M(-91.3%)
$3.69B(-7.6%)
Mar 2017
-
$2.56B(+2299.5%)
$3.99B(+52.4%)
Dec 2016
$2.62B(-24.5%)
$106.70M(-86.6%)
$2.62B(-19.1%)
Sep 2016
-
$799.10M(+51.3%)
$3.24B(+25.1%)
Jun 2016
-
$528.30M(-55.5%)
$2.59B(-16.1%)
Mar 2016
-
$1.19B(+63.7%)
$3.09B(-11.1%)
Dec 2015
$3.47B(+29.7%)
$725.00M(+386.3%)
$3.47B(+26.2%)
Sep 2015
-
$149.10M(-85.5%)
$2.75B(-10.2%)
Jun 2015
-
$1.03B(-34.7%)
$3.06B(+2.7%)
Mar 2015
-
$1.57B(>+9900.0%)
$2.98B(+11.4%)
Dec 2014
$2.68B(+10.6%)
$5.20M(-98.9%)
$2.68B(-1.7%)
Sep 2014
-
$460.30M(-51.3%)
$2.72B(-22.0%)
Jun 2014
-
$944.50M(-25.4%)
$3.49B(+23.3%)
Mar 2014
-
$1.27B(+2373.4%)
$2.83B(+16.9%)
Dec 2013
$2.42B(+10.1%)
$51.20M(-95.8%)
$2.42B(-18.2%)
Sep 2013
-
$1.23B(+332.4%)
$2.96B(+62.4%)
Jun 2013
-
$284.00M(-66.9%)
$1.82B(-6.9%)
Mar 2013
-
$857.60M(+45.4%)
$1.96B(-11.0%)
DateAnnualQuarterlyTTM
Dec 2012
$2.20B(-23.0%)
$590.00M(+547.6%)
$2.20B(+48.4%)
Sep 2012
-
$91.10M(-78.3%)
$1.48B(-45.0%)
Jun 2012
-
$419.30M(-61.9%)
$2.69B(-8.4%)
Mar 2012
-
$1.10B(-964.2%)
$2.94B(+3.0%)
Dec 2011
$2.85B(+195.8%)
-$127.20M(-109.8%)
$2.85B(-17.3%)
Sep 2011
-
$1.30B(+95.2%)
$3.45B(+17.6%)
Jun 2011
-
$667.10M(-34.1%)
$2.94B(+21.2%)
Mar 2011
-
$1.01B(+115.9%)
$2.42B(+150.8%)
Dec 2010
$965.30M(-63.7%)
$469.20M(-40.3%)
$965.30M(+130.0%)
Sep 2010
-
$785.70M(+411.9%)
$419.70M(-56.2%)
Jun 2010
-
$153.50M(-134.6%)
$959.20M(-12.3%)
Mar 2010
-
-$443.10M(+480.0%)
$1.09B(-58.9%)
Dec 2009
$2.66B(+21.5%)
-$76.40M(-105.8%)
$2.66B(-14.9%)
Sep 2009
-
$1.33B(+359.2%)
$3.12B(+19.6%)
Jun 2009
-
$288.60M(-74.3%)
$2.61B(+10.8%)
Mar 2009
-
$1.12B(+189.8%)
$2.36B(+7.7%)
Dec 2008
$2.19B(-45.6%)
$387.60M(-52.3%)
$2.19B(-21.7%)
Sep 2008
-
$812.90M(+2256.2%)
$2.80B(+15.3%)
Jun 2008
-
$34.50M(-96.4%)
$2.42B(-20.6%)
Mar 2008
-
$954.80M(-3.9%)
$3.05B(-24.1%)
Dec 2007
$4.02B(+4.5%)
$993.80M(+124.9%)
$4.02B(-8.5%)
Sep 2007
-
$441.90M(-33.3%)
$4.40B(-2.6%)
Jun 2007
-
$662.40M(-65.6%)
$4.51B(+12.4%)
Mar 2007
-
$1.92B(+40.7%)
$4.01B(+4.2%)
Dec 2006
$3.85B(+24.4%)
$1.37B(+145.5%)
$3.85B(+13.1%)
Sep 2006
-
$557.00M(+238.4%)
$3.40B(-9.0%)
Jun 2006
-
$164.60M(-90.7%)
$3.74B(-10.5%)
Mar 2006
-
$1.76B(+91.3%)
$4.18B(+35.1%)
Dec 2005
$3.09B(+165.3%)
$920.80M(+2.9%)
$3.09B(+12.8%)
Sep 2005
-
$895.10M(+47.8%)
$2.74B(+23.3%)
Jun 2005
-
$605.60M(-10.1%)
$2.22B(+42.9%)
Mar 2005
-
$673.40M(+18.3%)
$1.56B(+33.5%)
Dec 2004
$1.17B(+12.9%)
$569.30M(+51.2%)
$1.17B(+18.2%)
Sep 2004
-
$376.60M(-704.5%)
$987.20M(+8.1%)
Jun 2004
-
-$62.30M(-122.0%)
$913.00M(-15.7%)
Mar 2004
-
$282.80M(-27.5%)
$1.08B(+4.9%)
Dec 2003
$1.03B(+19.0%)
$390.10M(+29.0%)
$1.03B(+6.7%)
Sep 2003
-
$302.40M(+180.3%)
$968.20M(-3.9%)
Jun 2003
-
$107.90M(-53.6%)
$1.01B(+6.6%)
Mar 2003
-
$232.30M(-28.7%)
$944.70M(+8.9%)
Dec 2002
$867.80M(+48.5%)
$325.60M(-4.7%)
$867.80M(+29.9%)
Sep 2002
-
$341.70M(+657.6%)
$668.00M(+20.2%)
Jun 2002
-
$45.10M(-71.0%)
$555.80M(-2.9%)
Mar 2002
-
$155.40M(+23.5%)
$572.40M(-2.0%)
Dec 2001
$584.20M(-4.4%)
$125.80M(-45.2%)
$584.20M(+27.4%)
Sep 2001
-
$229.50M(+272.0%)
$458.40M(+100.3%)
Jun 2001
-
$61.70M(-63.1%)
$228.90M(+36.9%)
Mar 2001
-
$167.20M
$167.20M
Dec 2000
$611.20M(+396.5%)
-
-
Dec 1999
$123.10M(+301.0%)
-
-
Dec 1998
$30.70M
-
-

FAQ

  • What is Elevance Health, Inc. annual free cash flow?
  • What is the all time high annual FCF for Elevance Health, Inc.?
  • What is Elevance Health, Inc. annual FCF year-on-year change?
  • What is Elevance Health, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Elevance Health, Inc.?
  • What is Elevance Health, Inc. quarterly FCF year-on-year change?
  • What is Elevance Health, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Elevance Health, Inc.?
  • What is Elevance Health, Inc. TTM FCF year-on-year change?

What is Elevance Health, Inc. annual free cash flow?

The current annual FCF of ELV is $4.55B

What is the all time high annual FCF for Elevance Health, Inc.?

Elevance Health, Inc. all-time high annual free cash flow is $9.67B

What is Elevance Health, Inc. annual FCF year-on-year change?

Over the past year, ELV annual free cash flow has changed by -$2.21B (-32.71%)

What is Elevance Health, Inc. quarterly free cash flow?

The current quarterly FCF of ELV is $1.79B

What is the all time high quarterly FCF for Elevance Health, Inc.?

Elevance Health, Inc. all-time high quarterly free cash flow is $6.17B

What is Elevance Health, Inc. quarterly FCF year-on-year change?

Over the past year, ELV quarterly free cash flow has changed by +$1.66B (+1341.13%)

What is Elevance Health, Inc. TTM free cash flow?

The current TTM FCF of ELV is $5.34B

What is the all time high TTM FCF for Elevance Health, Inc.?

Elevance Health, Inc. all-time high TTM free cash flow is $11.13B

What is Elevance Health, Inc. TTM FCF year-on-year change?

Over the past year, ELV TTM free cash flow has changed by +$4.52B (+550.85%)
On this page